News | September 05, 2024
Apollo Hospitals launches Apollo Research Academy
The Academy, led by Professor Ravi P Mahajan CBE, is set to harmonize the efforts of various Apollo entities
The Academy, led by Professor Ravi P Mahajan CBE, is set to harmonize the efforts of various Apollo entities
He will lead the final stages of work to commission the 54,000-square-foot facility and then lead ongoing operations at the site
PiaSky advances C5 inhibition through innovative recycling technology, which enables its monthly SC administration
The study highlighted substantial improvements in key clinical parameters among RA patients who underwent AWS intervention
Ordspono is Regeneron’s first approved bispecific antibody and will provide an off-the-shelf option that can be administered in the out-patient setting, with hope for complete remission
Winrevair is the first activin signaling inhibitor therapy for PAH approved in Europe
PiaSky advances C5 inhibition through innovative recycling technology, which enables its monthly SC administration
e brings over 27+ years of rich pharmaceutical experience
New Chair brings extensive experience in global pharmaceutical and biotechnology leadership, healthcare innovation, and strategic drug development
AGEasy has made significant strides in addressing the pressing health concerns of seniors in India
Subscribe To Our Newsletter & Stay Updated
